Literature DB >> 6977613

Prostaglandin E inhibits the production of human interleukin 2.

R S Rappaport, G R Dodge.   

Abstract

Prostaglandins of the E type specifically inhibited the production of interleukin 2 (IL-2) by normal human lymphocytes, whereas PG synthetase inhibitors such as indomethacin and fentiazac raised IL-2 production above normal levels. Removal of adherent cells from mononuclear cell populations also resulted in enhanced IL-2 production. The resultant nonadherent cell population lost sensitivity to the enhancement effect of PG synthetase inhibitors, suggesting that a PGE-producing adherent cell plays a major role in the regulation of IL-2.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 6977613      PMCID: PMC2186623          DOI: 10.1084/jem.155.3.943

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  15 in total

1.  Characterization of lymphocyte-activating factor (LAF) produced by the macrophage cell line, P388D1. I. Enhancement of LAF production by activated T lymphocytes.

Authors:  S B Mizel; J J Oppenheim; D L Rosenstreich
Journal:  J Immunol       Date:  1978-05       Impact factor: 5.422

Review 2.  Prostaglandins and the immune response.

Authors:  L M Pelus; H R Strausser
Journal:  Life Sci       Date:  1977-03-15       Impact factor: 5.037

3.  Selective in vitro growth of T lymphocytes from normal human bone marrows.

Authors:  D A Morgan; F W Ruscetti; R Gallo
Journal:  Science       Date:  1976-09-10       Impact factor: 47.728

4.  Control of lymphokine secretion by prostaglandins.

Authors:  D Gordon; M A Bray; J Morley
Journal:  Nature       Date:  1976-07-29       Impact factor: 49.962

5.  Inhibition of prostaglandin synthesis as a mechanism of action for aspirin-like drugs.

Authors:  J R Vane
Journal:  Nat New Biol       Date:  1971-06-23

Review 6.  Regulation of the immune response by prostaglandins.

Authors:  J S Goodwin; D R Webb
Journal:  Clin Immunol Immunopathol       Date:  1980-01

7.  Two distinct factors are required for induction of T-cell growth.

Authors:  E L Larsson; N N Iscove; A Coutinho
Journal:  Nature       Date:  1980-02-14       Impact factor: 49.962

8.  Prostaglandins as regulators in cellular immunity.

Authors:  M A Bray; D Gordon; J Morley
Journal:  Prostaglandins Med       Date:  1978-09

9.  Prostaglandin suppression of mitogen-stimulated lymphocytes in vitro. Changes with mitogen dose and preincubation.

Authors:  J S Goodwin; R P Messner; G T Peake
Journal:  J Clin Invest       Date:  1978-10       Impact factor: 14.808

10.  Suppression of human T-cell mitogenesis by prostaglandin. Existence of a prostaglandin-producing suppressor cell.

Authors:  J S Goodwin; A D Bankhurst; R P Messner
Journal:  J Exp Med       Date:  1977-12-01       Impact factor: 14.307

View more
  86 in total

1.  Oral aspirin and ibuprofen increase cytokine-induced synthesis of IL-1 beta and of tumour necrosis factor-alpha ex vivo.

Authors:  S Endres; R E Whitaker; R Ghorbani; S N Meydani; C A Dinarello
Journal:  Immunology       Date:  1996-02       Impact factor: 7.397

Review 2.  Control of humoral immune responses by arachidonic acid metabolites.

Authors:  T W Behrens; J S Goodwin
Journal:  Agents Actions       Date:  1989-01

3.  Immunosuppressive actions of prostaglandins and the possible increase in chronic inflammation after cyclo-oxygenase inhibitors.

Authors:  G P Lewis; M L Barrett
Journal:  Agents Actions       Date:  1986-10

4.  Liver transplantation in positive cytotoxic crossmatch cases using FK506, high-dose steroids, and prostaglandin E1.

Authors:  S Takaya; Y Iwaki; T E Starzl
Journal:  Transplantation       Date:  1992-11       Impact factor: 4.939

5.  Decrease in interferon-gamma production by peripheral blood mononuclear cells in patients with uterine cervical cancer.

Authors:  H Mori; T Hanabayashi; Y Yamada; T Tamaya
Journal:  J Clin Immunol       Date:  1990-01       Impact factor: 8.317

6.  Effect of cyclosporin A and inhibitors of arachidonic acid metabolism on blood flow and cyclo-oxygenase products in rat skin allografts.

Authors:  T P Fan; G P Lewis
Journal:  Br J Pharmacol       Date:  1984-02       Impact factor: 8.739

7.  16, 16 Dimethyl prostaglandin E2 prevents the development of fulminant hepatitis and blocks the induction of monocyte/macrophage procoagulant activity after murine hepatitis virus strain 3 infection.

Authors:  M Abecassis; J A Falk; L Makowka; V J Dindzans; R E Falk; G A Levy
Journal:  J Clin Invest       Date:  1987-09       Impact factor: 14.808

8.  Regulation of IL-2 production by mononuclear cells from rheumatoid arthritis synovial fluids.

Authors:  E Flescher; T L Bowlin; N Talal
Journal:  Clin Exp Immunol       Date:  1992-03       Impact factor: 4.330

9.  The stimulation of IL-2 production by anti-rheumatic drugs.

Authors:  J A Oben; G R Wallace; B M Chain; J C Foreman
Journal:  Immunology       Date:  1989-07       Impact factor: 7.397

Review 10.  Inhibition of prostaglandin E2 formation and histamine action in cancer immunotherapy.

Authors:  P Uotila
Journal:  Cancer Immunol Immunother       Date:  1993-09       Impact factor: 6.968

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.